Cadflow.eu is designed to streamline and enhance the clinical workflow for coronary imaging. By combining automated image processing, AI‑driven analysis, and intuitive visualization tools, the platform helps clinicians interpret complex cardiology studies with greater confidence and efficiency in coming years.

Key capabilities include:

• AI‑assisted and Azure tools coronarography structure analysis for improved diagnostic accuracy (total over 200 thousand procedures in Romania per year)
• Automated segmentation and measurement tools that reduce manual workload
• Real‑time decision support during coronarography procedures
• Cloud‑based architecture enabling secure, scalable deployment across multiple sites
• Interoperability with existing PACS and hospital systems, ensuring smooth integration

For Affidea, the adoption of Cadflow.eu represents a strategic investment in next‑generation imaging technologies that elevate clinical quality while supporting operational efficiency across its network.

Accelerating Innovation Through Collaboration

The cooperation between Autosymed and Affidea for 2026 and 2027 reflects a broader trend in healthcare: the convergence of medical expertise, digital innovation, and AI‑driven diagnostics. By integrating Cadflow.eu hosted on Azure Cloud into its cardiology units, Affidea aims to:

• Enhance diagnostic precision in coronary imaging
• Reduce variability in image interpretation
• Shorten reporting times and improve patient throughput
• Support cardiologists and radiologists with advanced analytical tools
• Standardize high‑quality care across multiple European regions

Autosymed’s R&D team will work closely with Affidea’s clinical and technical specialists to ensure seamless deployment, continuous optimization, and alignment with local regulatory requirements.

A Milestone for Autosymed SRL

For Autosymed, the partnership is a major milestone in the company’s mission to bring cutting‑edge cardiovascular imaging solutions to clinical practice. The rapid multi‑country rollout demonstrates both the scalability of Cadflow.eu and the trust placed in the platform by one of Europe’s most respected healthcare groups.

The collaboration also opens the door to future joint initiatives in:

• AI‑driven diagnostic research
• Clinical validation studies
• Workflow optimization projects
• Expansion into additional imaging modalities

Autosymed positions itself as a key innovator in the European med‑tech landscape, with Cadflow.eu serving as a flagship example of how AI can meaningfully support clinical decision‑making.

About Affidea Group

Affidea is one of Europe’s largest and fastest‑growing providers of diagnostic imaging, outpatient services, and cancer care. Operating in 16 countries with more than 400 centers, the group serves millions of patients annually. Affidea is known for its commitment to clinical excellence, patient safety, and the adoption of innovative technologies that enhance diagnostic accuracy and care quality.